Dynamic cross-regulation of antigen-specific effector and regulatory T cell subpopulations and microglia in brain autoimmunity.

Abstract

BACKGROUND:

Multiple Sclerosis (MS) is considered a T-cell-mediated autoimmune disease with a prototypical oscillatory behavior, as evidenced by the presence of clinical relapses. Understanding the dynamics of immune cells governing the course of MS, therefore, has many implications for immunotherapy. Here, we used flow cytometry to analyze the time-dependent behavior of antigen-specific effector (T(eff)) and regulatory (T(reg)) T cells and microglia in mice model of MS, Experimental Autoimmune Encephalomyelitis (EAE), and compared the observations with a mathematical cross-regulation model of T-cell dynamics in autoimmune disease.

RESULTS:

We found that T(eff) and T(reg) cells specific to myelin olygodendrocyte glycoprotein (MOG) developed coupled oscillatory dynamics with a 4- to 5-day period and decreasing amplitude that was always higher for the T(eff) populations, in agreement with the mathematical model. Microglia activation followed the oscillations of MOG-specific T(eff) cells in the secondary lymphoid organs, but they were activated before MOG-specific T-cell peaks in the CNS. Finally, we assessed the role of B-cell depletion induced by anti-CD20 therapy in the dynamics of T cells in an EAE model with more severe disease after therapy. We observed that B-cell depletion decreases T(eff) expansion, although its oscillatory behavior persists. However, the effect of B cell depletion was more significant in the T(reg) population within the CNS, which matched with activation of microglia and worsening of the disease. Mathematical modeling of T-cell cross-regulation after anti-CD20 therapy suggests that B-cell depletion may influence the dynamics of T cells by fine-tuning their activation.

CONCLUSIONS:

The oscillatory dynamics of T-cells have an intrinsic origin in the physiological regulation of the adaptive immune response, which influences both disease phenotype and response to immunotherapy.

• Authors: Sara Martinez-Pasamar, Elena Abad, Beatriz Moreno, Nieves Velez de Mendizabal, Ivan Martinez-Forero, Jordi Garcia-Ojalvo, Pablo Villoslada
• Journal: BMC systems biology (BMC Syst Biol) Vol. 7 Pg. 34 (Apr 26 2013) ISSN: 1752-0509 [Electronic] England
• PMID: 23618467 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Antibodies
• Antigens, CD20
• Myelin-Oligodendrocyte Glycoprotein

Topics

• Animals
• Antibodies (immunology, therapeutic use)
• Antigens, CD20 (immunology)
• Autoimmunity
• B-Lymphocytes (immunology)
• Brain (immunology, pathology)
• Encephalomyelitis, Autoimmune, Experimental (drug therapy, immunology)
• Humans
• Mice
• Mice, Inbred C57BL
• Microglia (immunology, pathology)
• Multiple Sclerosis (immunology)
• Myelin-Oligodendrocyte Glycoprotein (immunology)
• Recurrence
• Spleen (immunology)
• T-Lymphocytes, Regulatory (immunology)